Multicomponent intervention to reduce daily sedentary time: a randomised controlled trial

The researchers tested a three-part intervention designed to reduce sedentary time in people with desk jobs:

**Intervention group:** Received (1) a theory-based internet-delivered programme (website with goal-setting, self-monitoring, feedback, and educational modules), (2) a portable pedal machine (a small under-desk elliptical device) to use at work, and (3) a pedometer to track steps. The intervention lasted 12 weeks.

**Control group:** A wait-list control group that maintained their usual behaviours for 12 weeks, then received the intervention after the study ended.

**Primary outcome:** Daily sedentary time (minutes per day) measured objectively by a StepWatch activity monitor worn on the ankle.

**Secondary outcomes:** Heart rate, blood pressure, height, weight, waist circumference, percent body fat, cardiorespiratory fitness (estimated from a submaximal treadmill test), and fasting lipids (total cholesterol, HDL, LDL, triglycerides).

**Exploratory outcomes:** Intervention compliance (website logins, pedal machine use, pedometer wear) and process evaluation (satisfaction surveys).

**Sample size:** 49 participants enrolled; 40 completed the study (23 intervention, 17 control). The 9 dropouts were not included in the final analysis.

**Population:** Middle-aged, primarily female, sedentary and overweight adults working in sedentary jobs at a large southeastern US university.

**Specific demographics:**

- Intervention group: Mean age 47.6 years (SD 9.9); 94.1% female; mean BMI 33.2 kg/m² (SD 4.5) — class I obese.

- Control group: Mean age 42.6 years (SD 8.9); 86.9% female; mean BMI 31.7 kg/m² (SD 4.9) — class I obese.

**Inclusion criteria:** Age 21–65 years; employed full-time in a sedentary job (self-reported sitting ≥75% of workday); BMI ≥25 kg/m² (overweight or obese); self-reported sedentary (<150 minutes of moderate-to-vigorous physical activity per week); access to a computer with internet at work; willing to be randomised.

**Exclusion criteria:** Current use of a standing desk or pedal machine; pregnancy; uncontrolled hypertension; cardiovascular disease; musculoskeletal problems preventing pedalling; taking medications affecting heart rate or metabolism.

**Primary outcome — sedentary time:** Measured using the StepWatch 3.0 activity monitor (Orthocare Innovations, Oklahoma City, Oklahoma, USA). This is a small, waterproof device worn on the ankle that counts steps and estimates time spent in different activity intensities (sedentary, light, moderate, vigorous) based on step rate. Participants wore it for 7 consecutive days at baseline and again for 7 consecutive days at 12 weeks (post-intervention). The monitor was worn during all waking hours except when bathing or swimming.

**Secondary outcomes:**

- **Heart rate and blood pressure:** Measured using an automated blood pressure monitor (Omron HEM-907XL) after 5 minutes of seated rest. Three readings were taken, and the average of the last two was used.

- **Anthropometrics:** Height (stadiometer), weight (digital scale), waist circumference (at the umbilicus using a Gulick tape measure), percent body fat (bioelectrical impedance analysis using a Tanita TBF-300A scale).

- **Cardiorespiratory fitness:** Estimated from a submaximal treadmill test using the YMCA protocol (3-minute stages at increasing speed/incline until 85% of age-predicted maximum heart rate was reached). VO₂max was estimated from the heart rate response.

- **Fasting lipids:** Blood samples were drawn after a 12-hour fast and analysed for total cholesterol, HDL cholesterol, LDL cholesterol (calculated), and triglycerides using standard enzymatic methods.

**Exploratory outcomes:**

- **Website compliance:** Number of days participants logged into the intervention website (tracked automatically).

- **Pedal machine use:** Self-reported daily minutes of pedal machine use (logged on the website).

- **Pedometer wear:** Self-reported days per week the pedometer was worn.

- **Process evaluation:** A post-intervention survey asking about satisfaction, ease of use, and likelihood of continuing.

**Study design:** This was a blinded, randomised controlled trial (RCT). Participants were randomly assigned to either the intervention group or a wait-list control group using a computer-generated random number sequence. The randomisation was stratified by sex to ensure balance. The study was "blinded" in the sense that outcome assessors (those measuring blood pressure, fitness, etc.) were unaware of group assignment. Participants and the intervention delivery team were not blinded (they knew which group they were in).

**Duration:** The intervention lasted 12 weeks. Measurements were taken at baseline (week 0) and post-intervention (week 12). The control group received the intervention after the 12-week study period ended.

**Statistical approach:** The primary analysis used analysis of covariance (ANCOVA) to compare post-intervention outcomes between groups, adjusting for baseline values and monitor wear time (for the sedentary time outcome). This is appropriate because it accounts for any pre-existing differences between groups and reduces error variance. The authors reported mean changes from baseline with 95% confidence intervals and p-values. They also performed an intention-to-treat analysis (including all randomised participants, even dropouts) using last observation carried forward, but the primary results reported are from the completers analysis (N=40).

**What this design can and cannot prove:**

**Can prove:** Because this is a randomised controlled trial with a control group, it can establish causality — the intervention caused the reduction in sedentary time, not some other factor. Randomisation ensures that, on average, the two groups are equivalent at baseline, so any difference at 12 weeks is likely due to the intervention. The blinding of outcome assessors reduces measurement bias.

**Cannot prove:** The study cannot tell us which component of the intervention (website, pedal machine, pedometer) was most effective — it tested a "bundle." It also cannot tell us whether the effects persist beyond 12 weeks (no follow-up). The small sample size (N=40 completers) limits statistical power to detect small effects, especially for secondary outcomes. The wait-list control design means the control group knew they would eventually get the intervention, which might have reduced their motivation to change behaviour on their own (though this is unlikely to have biased the results in favour of the intervention). The lack of blinding of participants means the placebo effect (expectation of benefit) could have contributed to the results, though objective measurement of sedentary time reduces this concern.

**Major methodological weaknesses:**

High dropout rate (9/49 = 18.4%), and the completers analysis may overestimate the effect if dropouts were less compliant.

Self-reported pedal machine use (not objectively verified).

No blinding of participants (unavoidable in a behavioural intervention, but still a limitation).

Short duration (12 weeks) with no follow-up to assess maintenance.

Single site (one university), limiting generalisability.

The control group was not given a placebo or attention control (e.g., a sham website or non-functional device), so the effect of "getting something" vs. "getting nothing" cannot be separated from the specific effect of the intervention components.

**Primary outcome — daily sedentary time:**

The intervention group reduced daily sedentary time by an average of 58.7 minutes per day (95% CI: -118.4 to 0.99 minutes; p < 0.01) compared to the control group, after adjusting for baseline values and monitor wear time.

In absolute terms: The intervention group decreased from a baseline mean of 546.3 minutes/day (9.1 hours) to 487.6 minutes/day (8.1 hours) — a reduction of 58.7 minutes. The control group changed from 547.8 minutes/day to 548.1 minutes/day (essentially no change).

**Secondary outcomes (none reached statistical significance at p < 0.05):**

**Systolic blood pressure:** Intervention group decreased by 2.1 mm Hg; control group decreased by 0.8 mm Hg. Between-group difference: -1.3 mm Hg (95% CI: -6.8 to 4.2; p = 0.64).

**Diastolic blood pressure:** Intervention group decreased by 1.4 mm Hg; control group increased by 0.4 mm Hg. Between-group difference: -1.8 mm Hg (95% CI: -5.6 to 2.0; p = 0.35).

**Waist circumference:** Intervention group decreased by 0.7 cm; control group decreased by 0.2 cm. Between-group difference: -0.5 cm (95% CI: -2.5 to 1.5; p = 0.62).

**Percent body fat:** Intervention group decreased by 0.3%; control group decreased by 0.1%. Between-group difference: -0.2% (95% CI: -1.2 to 0.8; p = 0.69).

**Cardiorespiratory fitness (estimated VO₂max):** Intervention group increased by 0.5 mL/kg/min; control group decreased by 0.3 mL/kg/min. Between-group difference: 0.8 mL/kg/min (95% CI: -0.8 to 2.4; p = 0.32).

**Fasting lipids:** No significant between-group differences for total cholesterol, HDL, LDL, or triglycerides (p-values all > 0.05).

**Exploratory outcomes (compliance):**

Participants logged into the website on 71.3% of all intervention days (mean 59.9 out of 84 days).

Participants used the pedal machine on 37.7% of all working intervention days (mean 15.8 out of 42 working days).

When they used the pedal machine, they pedalled an average of 31.1 minutes per day.

Participants wore the pedometer on 5.7 out of 7 days per week (81.4% compliance).

**Process evaluation:**

82% of intervention participants reported they would continue using the pedal machine if given the opportunity.

76% reported the intervention was "very easy" or "easy" to incorporate into their workday.

71% reported they would recommend the programme to a coworker.

The intervention reduced daily sedentary time by approximately 59 minutes per day — roughly one hour. To put this in context:

This is equivalent to replacing about 10% of a typical 9.5-hour sedentary workday with light physical activity (pedalling).

The effect is similar in magnitude to what you might achieve by taking a 10-minute walking break every 90 minutes across an 8-hour workday.

For comparison, a typical lunch break is 30–60 minutes, so this intervention effectively "added" one lunch-break-sized chunk of movement to each day.

The effect was not large enough to produce statistically significant improvements in blood pressure, cholesterol, or body composition over 12 weeks, but the direction of change was favourable for most outcomes (small improvements in blood pressure, waist circumference, and fitness). The lack of significance may be due to the small sample size and short duration rather than a true absence of effect.

**Acknowledged by authors:**

Small sample size (N=40 completers) limited statistical power for secondary outcomes.

Short intervention duration (12 weeks) with no follow-up to assess long-term maintenance.

Self-reported pedal machine use (may be overestimated due to social desirability bias).

Single site (one university), limiting generalisability to other populations or work settings.

The control group was a wait-list control, not an attention control, so the effect of "receiving attention" cannot be separated from the specific intervention components.

The StepWatch monitor may not perfectly distinguish between sitting and standing still (both are classified as sedentary), so some standing time may have been misclassified.

**Additional critical concerns:**

High dropout rate (18.4%) and completers-only analysis may bias results toward showing a larger effect (if less motivated participants dropped out).

The sample was overwhelmingly female (90%+), so results may not generalise to men.

Participants were volunteers, likely more motivated than the general population of sedentary workers.

The intervention was a "bundle" — you cannot tell which component (website, pedal machine, pedometer) drove the effect. The website alone might have been sufficient, or the pedal machine alone might have been sufficient.

No objective measure of pedal machine use (e.g., a sensor on the machine) — compliance was self-reported.

The study did not measure whether participants compensated by being more sedentary outside of work hours (e.g., sitting more in the evening because they pedalled during the day).

The 95% confidence interval for the primary outcome (-118.4 to 0.99 minutes) includes values close to zero, meaning the true effect could be as small as 1 minute per day. The lower bound of the CI is more impressive (a reduction of nearly 2 hours), but the upper bound is barely a reduction at all.

For someone running their own n=1 experiment:

### What to test (specific intervention and dose)

**Intervention:** Use a portable under-desk pedal machine (or elliptical) during work hours, combined with a step-tracking device (pedometer or fitness tracker) and a daily log (paper or app) to track minutes pedalled and steps taken.

**Dose:** Aim to pedal for at least 30 minutes per workday (the average achieved in the study). This could be broken into smaller chunks (e.g., 10 minutes three times per day, or 15 minutes twice per day). The goal is to replace ~60 minutes of sitting with pedalling each day.

**Optional add-on:** Use a website or app with goal-setting, self-monitoring, and feedback (e.g., set a daily step goal, log your pedal time, review weekly trends).

### Minimum meaningful duration

**12 weeks** (the study duration) is a reasonable minimum to see a measurable change in sedentary time. For health outcomes (blood pressure, waist circumference, fitness), you may need **16–24 weeks** to see meaningful changes, given that the study found no significant improvements in these outcomes at 12 weeks.

For a self-experiment, consider running the intervention for **4–8 weeks** to test feasibility and compliance, then extend to **12 weeks** if you want to assess health outcomes.

### What to measure (specific metrics)

**Primary metric:** Daily sedentary time (minutes per day). Use an activity monitor (e.g., Fitbit, Garmin, Apple Watch, or a research-grade device like the StepWatch) that tracks sedentary vs. active time. Alternatively, use a simple log: record the time you start and stop pedalling each day, and estimate your total sitting time (e.g., using a timer or app).

**Secondary metrics:**

- Steps per day (from pedometer or fitness tracker).

- Pedal machine minutes per day (self-logged).

- Waist circumference (measured at the navel, same time of day, same tape measure).

- Resting heart rate (measured first thing in the morning, before getting out of bed, using a heart rate monitor or manual pulse check).

- Blood pressure (if you have a home monitor — measure at the same time each day, after 5 minutes of seated rest).

- Body weight (measured weekly, same day and time, after waking and using the bathroom).

**Process metrics:** How many days per week did you use the pedal machine? How many minutes per session? How easy was it to incorporate into your workday? (Rate 1–10.)

### Key confounds to control for

**Monitor wear time:** If you wear your activity monitor for different amounts of time